Literature DB >> 33331309

[Clinical characteristics and related factors of rheumatoid arthritis complicated with tuberculosis infection].

G Tang1, L Long2, Y X Han3, Q Peng4, J J Liu4, H Shang4.   

Abstract

OBJECTIVE: To investigate the clinical characteristics and high risk factors of Rheumatoid arthritis (RA) complicated with tuberculosis infection.
METHODS: Patients with rheumatoid arthritis diagnosed in the hospital of Sichuan Provincial People's Hospital from January 2007 to January 2017 was retrospectively collected, who were enrolled in the study group. A control group was randomly selected from the RA patients hospitalized in the same period without co-infection at a ratio of 1 :2. The general data, clinical data, laboratory test data, treatment plan, etc. of the two groups were collected in detail for single factor statistical analysis. Then multivariate Logistic regression was used to analyze the independent risk factors of RA complicated with tuberculosis infection with statistical significance in univariate analysis.
RESULTS: The clinical manifestations of fever (83.3%) were most common, followed by cough (69%) and body mass loss (45.2%). In the infected group, pulmonary tuberculosis accounted for 73.3%. In the infected group the chest CT showed two or more cases, accounting for 59%. There were 9 cases (33.3%) occurring in the typical tuberculosis occurrence site. Compared with the control group, the erythrocyte sedimentation rate (ESR), C-reaction protein (CRP) levels, and the daily average dose of glucocorticoid in 1 year in the infected group were higher than those in the control group. And those differences were statistically significant(P < 0.05). There were no significant differences in gender, age, disease duration, disease activity score, white blood cell (WBC), platelet (PLT), hemoglobin (Hb), immunoglobulin G (IgG), complement (C), Anti cyclic citrullinated peptide antibody (anti-CCP), CD4+T cell count, and immunosuppressant use (P > 0.05). Multivariate Logistic regression analysis showed that CRP levels(OR=1.016, 95%CI:1.002-1.031) and the daily average dose of glucocorticoid in 1 year(OR=1.229, 95%CI:1.066-1.418)were the independent risk factors of RA complica-ted with tuberculosis infection.
CONCLUSION: RA patients with tuberculosis infection are mainly phthisis. The clinical manifestations of RA combined with tuberculosis infection are lack of specificity, and the chest imaging features of pulmonary tuberculosis are diverse, which are easy to be misdiagnosed. CRP levels and the daily average dose level of glucocorticoid in 1 year were risk factors for RA and tuberculosis infection.

Entities:  

Keywords:  Rheumatoid arthritis; Risk factor; Tuberculosis

Mesh:

Substances:

Year:  2020        PMID: 33331309      PMCID: PMC7745273     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  11 in total

1.  Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis.

Authors:  Alejandro Balsa; Loreto Carmona; Isidoro González-Alvaro; Miguel Angel Belmonte; Xavier Tena; Raimon Sanmartí
Journal:  J Rheumatol       Date:  2004-01       Impact factor: 4.666

Review 2.  Tuberculosis and biologics in rheumatology: A special situation.

Authors:  Rohini Handa; Sundeep Upadhyaya; Sanjiv Kapoor; Ramesh Jois; Bimlesh D Pandey; Anuj K Bhatnagar; Ashwani Khanna; Vishal Goyal; Kamal Kumar
Journal:  Int J Rheum Dis       Date:  2017-07-21       Impact factor: 2.454

3.  Trends in serious infections in rheumatoid arthritis.

Authors:  Orla M Ni Mhuircheartaigh; Eric L Matteson; Abigail B Green; Cynthia S Crowson
Journal:  J Rheumatol       Date:  2013-04-01       Impact factor: 4.666

4.  A retrospective study on the risk of tuberculosis in patients with rheumatoid arthritis.

Authors:  Tin Tsun Chung; Ho Juen Ko; Chak Sing Lau; Ho Yin Chung
Journal:  Rheumatol Int       Date:  2020-04-21       Impact factor: 2.631

Review 5.  Infection Risk and Safety of Corticosteroid Use.

Authors:  Jameel Youssef; Shannon A Novosad; Kevin L Winthrop
Journal:  Rheum Dis Clin North Am       Date:  2015-10-24       Impact factor: 2.670

6.  Disseminated tuberculosis masquerading as a presentation of systemic lupus erythematosus.

Authors:  Justin C-H Li; Warren Fong; Limin Wijaya; Ying Y Leung
Journal:  Int J Rheum Dis       Date:  2017-10-02       Impact factor: 2.454

Review 7.  Lung Infections in Systemic Rheumatic Disease: Focus on Opportunistic Infections.

Authors:  Manuela Di Franco; Bruno Lucchino; Martina Spaziante; Cristina Iannuccelli; Guido Valesini; Giancarlo Iaiani
Journal:  Int J Mol Sci       Date:  2017-01-29       Impact factor: 5.923

Review 8.  Latent tuberculosis infection in patients with rheumatic diseases.

Authors:  Camila Anton; Felipe Dominguez Machado; Jorge Mario Ahumada Ramirez; Rafaela Manzoni Bernardi; Penélope Esther Palominos; Claiton Viegas Brenol; Fernanda Carvalho de Queiroz Mello; Denise Rossato Silva
Journal:  J Bras Pneumol       Date:  2019-04-25       Impact factor: 2.624

Review 9.  Finding the Missing Patients With Tuberculosis: Lessons Learned From Patient-Pathway Analyses in 5 Countries.

Authors:  Christy Hanson; Mike Osberg; Jessie Brown; George Durham; Daniel P Chin
Journal:  J Infect Dis       Date:  2017-11-06       Impact factor: 5.226

10.  The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan.

Authors:  Chong Hong Lim; Hsin-Hua Chen; Yi-Hsing Chen; Der-Yuan Chen; Wen-Nan Huang; Jaw-Ji Tsai; Tsu-Yi Hsieh; Chia-Wei Hsieh; Wei-Ting Hung; Ching-Tsai Lin; Kuo-Lung Lai; Kuo-Tung Tang; Chih-Wei Tseng; Yi-Ming Chen
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

View more
  2 in total

1.  Delayed Diagnosis: Tuberculous Arthritis of Right Knee Joint in a Patient with Rheumatoid Arthritis.

Authors:  H Senarathna; K Deshapriya
Journal:  Case Rep Rheumatol       Date:  2021-12-26

2.  Trends of adverse events and mortality after DMARDs in patients with rheumatoid arthritis: Interrupted time-series analysis.

Authors:  Yao-Fan Fang; Jia-Rou Liu; Shu-Hao Chang; Chang-Fu Kuo; Lai-Chu See
Journal:  Immun Inflamm Dis       Date:  2022-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.